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Abstract
Selenium (Se) can protect endothelial cells (EC) from oxidative damage by altering the expression of selenoproteins with antioxidant
function such as cytoplasmic glutathione peroxidase (cyGPX), phospholipid hydroperoxide glutathione peroxidase (PHGPX) and thioredoxin
reductase (TR). If the role of Se on EC function is to be studied, it is essential that a model system be chosen which reflects selenoprotein
expression in human EC derived from vessels prone to developing atheroma. We have used [75Se]-selenite labelling and selenoenzyme
measurements to compare the selenoproteins expressed by cultures of EC isolated from different human vasculature with EC isolated from
bovine and porcine aorta. Only small differences were observed in selenoprotein expression and activity in EC originating from human
coronary artery, human umbilical vein (HUVEC), human umbilical artery and the human EC line EAhy926. The selenoprotein profile in
HUVEC was consistent over eight passages and HUVEC isolated from four cords also showed little variability. In contrast, EC isolated from
pig and bovine aorta showed marked differences in selenoprotein expression when compared to human cells. This study firmly establishes the
suitability and consistency of using HUVEC (and possibly the human cell line EAhy926) as a model to study the effects of Se on EC function
in relation to atheroma development in the coronary artery. Bovine or porcine EC appear to be an inappropriate model.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The intake of selenium (Se) can to be inversely correlated
with the incidence of atherosclerosis and coronary heart
disease [1,2]. Oxidative damage to the endothelium is
thought to be a primary event in the pathogenesis of
atherosclerosis and Se, added as selenite, can protect the
EC from such damage by altering the expression of specific
selenoproteins [3,4]. The intracellular selenoproteins iden-
tified to date as having a potential antioxidant function
include cytoplasmic glutathione peroxidase (cyGPX), phos-
pholipid hydroperoxide glutathione peroxidase (PHGPX)
and isoenzymes of thioredoxin reductase (TR).
Labelling cells with [75Se]-selenite provides a sensitive
method for assessing the expression of selenoproteins. Since
equilibration of exogenous [75Se]-selenite with the endoge-
nous pool of Se and selenoproteins can take in excess of 24
h [5,6], such labelling experiments require incubation with
[75Se]-selenite for 36–48 h. Using these techniques to detect
selenoproteins in human umbilical vein endothelial cells
(HUVEC), TR has been identified as the predominant
selenoprotein comprising 43% of the total selenoproteins
[6]. Both cyGPX and PHGPX are also expressed by
cultured EC obtained from a number of species including
humans [4,7,8] but the relative activities of TR in EC
isolated from different species have not been defined.
The culture of EC derived from the large vasculature is a
well-established model for the study of the endothelium.
Ideally, EC isolated from human coronary arteries would be
preferred for studies relating to cardiovascular disease in man
since atheroma is common in these vessels and is a major
cause of morbidity and mortality. In practice, the human
umbilical vein is often the chosen source of EC for the study
of human endothelial function because of its accessibility.
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Moreover, it is a non-branching vessel with a large intimal
surface area, making it technically easy to isolate cells.
Unfortunately, the viability of isolated EC can be modified
by several factors including foetal stress, maternal anaesthe-
sia, smoking and other toxins [9,10]. The use of HUVEC and
other primary cultures of EC is also complicated by genetic
variability between preparations, limited population dou-
blings and the requirement for specialised growth factors.
Arterial and venous EC show differences in the production of
angiotensin-converting enzyme [11] and their response to
cytokine stimulation [12]. These observations have led to the
suggestion that HUVEC, despite being widely used by
researchers in the field of vascular disease, may not be the
most suitable model for studying human cardiovascular
disease [13–15].
Bovine aortic endothelial cells (BAEC) and porcine aortic
endothelial cells (PAEC) are also often used as models to
study EC function. PAEC may be a suitable alternative to
HUVEC since there are similarities between the porcine and
human cardiovascular system [16]. In addition, porcine aorta
is subject to atheroma formation and has been used as amodel
for the study of this process [17]. However, variation between
EC isolated from different species has been acknowledged to
occur; for example, PAEC, unlike HUVEC and BAEC, do
not express Factor VIII-related antigen [17].
The EC line EAhy926, established by hybridising pri-
mary HUVEC with A549 human lung tumour cells [18], has
been used in a number of studies of EC function. EAhy926
retain many of the differentiated functions common to
primary EC beyond 100 passages. These functions include:
the expression of von Willebrand Factor [18]; prostacyclin
formation [19]; expression of endothelin-1 [20]. The sele-
noprotein profile of EAhy926 cells has not been previously
determined, but such work is essential in order to establish
whether this convenient cell line would provide a suitable
model for future studies of selenoprotein expression in EC.
If the role of Se on EC function is to be studied, it is
essential that a model system be chosen which reflects the
selenoprotein expression and function of human EC derived
from vessels prone to developing atheroma. The experi-
ments reported here use [75Se]-selenite labelling and
enzyme measurements to compare the selenoproteins
expressed by cultures of EC isolated from different human
vasculature with EC isolated form bovine and porcine aorta.
The selenoprotein profile of the human EC cell line
EAhy926 has also been studied.
2. Methods
2.1. Isolation and culture of EC
2.1.1. HUVEC and human umbilical artery endothelial cells
(HUAEC)
Human umbilical cords ( > 100 mm in length) were
obtained at normal deliveries or Caesarean section from
nonsmoking women. Immediately after delivery, the cords
were placed into sterile Earle’s balanced salt solution
(EBSS) containing penicillin (100 units/ml), streptomycin
(100 Ag/ml) and amphotericin B (2.5 Ag/ml) and kept at 4
jC. EC were isolated within 20 h of delivery using a method
adapted from that described previously by Anema et al. [6]
and Jaffe et al. [21]. Cells were cultured in Endothelial
Growth Medium-2 (EGM-2: Biowhittaker, Berkshire, UK)
containing penicillin (100 units/ml), streptomycin (100 Ag/
ml) and amphotericin B (2.5 Ag/ml) at 37 jC in an
atmosphere of 5% CO2, 95% air.
The cells showed the morphology characteristic of EC in
culture previously described by Jaffe et al. [21]. Cells also
synthesised von Willebrand Factor as determined by an
indirect immuno-fluorescent detection system.
2.1.2. Human coronary arterial endothelial cells (HCAEC)
These were purchased from Biowhittaker, and tested
positive for the presence of von Willebrand Factor and
acetylated LDL (an alternative method for the specific
characterisation of EC in culture) [22]. The HCAEC also
displayed the characteristic morphology of EC. HCAECwere
maintained in EGM-2 containing penicillin (100 units/ml),
streptomycin (100 Ag/ml) and amphotericin B (2.5 Ag/ml),
and cultured at 37 jC in an atmosphere of 5% CO2, 95% air.
2.1.3. EAhy926 EC line
EAhy926 cells were kindly donated by Professor Cora-
Jean Edgell of the University of North Carolina, North
Carolina, USA. The cells were maintained in high glucose
(4.5 g/l) Dulbeco’s Modified Eagle’s medium (DMEM)
containing 10% foetal bovine serum (FBS), 5 mM hypoxan-
thine , 0.02 mM aminopterin, 0.8 mM thymidine, penicillin
(100 units/ml), streptomycin (100 Ag/ml) and amphotericin B
(2.5 Ag/ml). The cells were incubated at 37 jC in an
atmosphere of 5% CO2, 95% air and were passaged weekly
using 0.25% trypsin–0.02% EDTA solution. EAhy926 cells
displayed the characteristic morphology of EC in culture and
stained positive for vWF.
2.1.4. BAEC
These were purchased from Biowhittaker. The certificate
of analysis supplied with this product stated that the BAEC
tested positive for acetylated LDL. The cells were maintained
in EGM (Biowhittaker) containing penicillin (100 units/ml),
streptomycin (100 Ag/ml) and amphotericin B (2.5 Ag/ml)
and incubated at 37 jC in an atmosphere of 5% CO2, 95% air.
2.1.5. PAEC
Porcine aorta was obtained within 5–10 min of slaughter
from pigs aged under 2 years and was immediately placed
into sterile EBSS at 4 jC containing penicillin (100 units/ml),
streptomycin (100 Ag/ml) and amphotericin B (2.5 Ag/ml).
EC were isolated within 2–3 h of dissection using a method
adapted from that previously described by Slater and Sloan
[16]. Briefly, segments of about 5–10 cm were cut and any
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Fig. 1. Left. Autoradiograph of an SDS-PAGE gel of the intracellular selenoproteins of HUVEC labelled with [75Se]-selenite (0.02 MBq/ml) for various lengths of time over a 96-h period. Duplicate flasks of
HUVEC were labelled for each time point. Lanes 1, 2: 12 h; lanes 3, 4: 24 h; lanes 5, 6: 48 h; lanes 7, 8: 72 h; lanes 9, 10: 96 h. Each lane was loaded with 25-Ag protein. Middle. Autoradiographs of four SDS-
PAGE gels showing the intracellular selenoproteins from four different preparations of HUVEC labelled with [75Se]-selenite (0.02 MBq/ml) for 48 h. Each lane was loaded with 25 Ag of protein. Right.
Autoradiograph of an SDS-PAGE gel of a single isolation of HUVEC at different passages each labelled with [75Se]-selenite (0.02 MBq/ml) for 48 h. Lanes 1 to 8 represent passages 1 to 8, respectively. Each lane






































minor vessels were ligated. The segments were washed with
approximately 25 ml of EBSS (prewarmed to 37 jC). One
end of the aorta was then clamped shut and the opposite end
infused with 0.1% collagenase in EBSS (approximately 10
ml). This end was then closed and the cord incubated at 37
jC in an atmosphere of 5% CO2, 95% air. After 15 min the
segment was gently massaged and the contents collected
into a sterile universal container. The vessel was then cut
along its longitudinal axis and the luminal surface gently
scraped gently with a sterile stainless steel scalpel blade
angled at approximately 60j to the intimal surface. The
blade was washed with EBSS and the washings added to the
cell suspension previously collected. The sample was then
centrifuged at 450 g for 10 min and the resulting cell
pellet was washed with the culture medium [M199
containing 20% FBS, penicillin (100 units/ml), streptomy-
cin (100 Ag/ml) and amphotericin B (2.5 Ag/ml)]. The cells
were resuspended into a 25-cm2 flask and incubated at 37
jC in an atmosphere of 5% CO2, 95% air. The growth
medium was changed and replaced after 24 h and then on
alternate days. Cells displayed the characteristic morphol-
ogy of EC.
2.2. Time-course of [75Se]-labelling in HUVEC
HUVEC were isolated and maintained as described
previously. For labelling with 75Se-selenite, cells were
grown to confluence and the culture medium was changed
and replaced with fresh medium containing [75Se]-selenite
(0.02 MBq/ml). At time 0, 12, 24, 48, 72 and 96 h, the
medium was removed from all the flasks and the cells were
washed three times with EBSS (4 jC). The cells were
harvested into 20 ml of EBSS by scraping and centrifuged
at 2000 g for 10 min at 4 jC. The supernatant was
aspirated and the cell pellet resuspended in 200 Al of 60
mM Tris buffer, pH 7.8, containing 1 mM EDTA and 1 mM
dithiothreitol (Tris buffer). The cells were then lysed by
sonication whilst kept at 4 jC on ice.
Protein concentrations were measured using the Bradford
assay [23] and the samples were diluted to a common protein
concentration with Tris buffer. The cell lysates were subjected
to SDS-polyacrylamide gel electrophoresis to separate the
[75Se]-labelled proteins present in 25 Ag of protein. The
resulting gel was dried and the [75Se]-labelled selenoproteins
were visualised by autoradiography using Kodak X-OMAT
XAR-5 film.
2.3. The effect of passage number on [75Se]-labelling in
HUVEC
The intracellular [75Se]-selenoprotein profiles of eight
passages of a preparation of HUVEC isolated from a single
umbilical vein were compared. HUVEC were isolated and
maintained as described above. The HUVEC from the
primary isolate (passage zero) were grown to confluence
and passaged into at least three T75 flasks (passage one). At
confluence, HUVEC in two of the T75 flasks were labelled
with [75Se]-selenite (0.02 MBq/ml) for 48 h, whilst the third
was subcultured further to provide passage two. This proce-
dure was continued until cells had reached passage eight, at
which point distinct morphological changes were observed,
such as significant cell enlargement and a partial loss of the
characteristic cobblestone appearance.
After a 48-h labelling period, cells from each passage were
harvested and stored at  20 jC. Samples were thawed, lysed
and prepared for separation using SDS-PAGE as described
above.
2.4. The [75Se]-labelling of vascular EC isolated from
different vasculature
The intracellular selenoprotein profile of HUVEC,
HCAEC, HUAEC, EAhy926, BAEC and PAEC were
compared. Each cell type was isolated and maintained
as previously described above and labelled for 48 h with
[75Se]-selenite (0.02 MBq/ml) prior to SDS-PAGE elec-
trophoresis. For HUVEC, the selenoprotein profiles in
Fig. 2. Autoradiograph of an SDS-PAGE gel of the intracellular
selenoproteins of HUVEC and HCAEC labelled with [75Se]-selenite
(0.02 MBq/ml) for 48 h. Lane 1, HUVEC; lane 2, HCAEC. Each lane
was loaded with 25-Ag protein. The selenoprotein bands representing
cyGPX, PHGPX and TR are indicated.
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four different preparations of cells isolated from four
different cords were also compared.
2.5. Glutathione peroxidase and TR in EC
For each cell type the activities of TR, cGPX and
PHGPX were measured in parallel subcultures of EC grown
in triplicate 75-cm2 flasks using the same culture medium as
was used for the 75Se labelling experiments. The activity of
the selenoenzymes in EAhy926 cells was measured in cells
grown in the DMEM culture medium specified above in the
presence or absence of 40 nM selenite. After culture, cells
were harvested by scrapping and lysed in 0.125 M potas-
sium phosphate buffer (pH 7.4) by sonication on ice. TR
concentration was measured by an in-house radioimmuno-
assay using antiserum raised against human placental TR.
The activity of TR was determined using 5,5V-dithiobis 2-
nitrobenzoic acid (DTNB) as substrate in the presence and
absence of 720 nM gold thioglucose [24]. The activities of
cyGPX and PHGPX activity were determined as described
previously [25].
2.6. Se content of culture medium
The Se content of the culture medium used for each cell
type was determined using a fluorometric assay as described
by Olsen et al. [26].
2.7. Statistical analysis
An unpaired Student’s t test (with Welch correction when
appropriate) was used to test for significant differences
between the levels of TR, cyGPX and PHGPX.
3. Results
3.1. [75Se]-labelling in HUVEC
Fig. 1 (left panel) shows the autoradiograph of a SDS-
PAGE gel demonstrating the changes in [75Se]-labelling
over time. Selenoproteins were only faintly labelled after a
12-h exposure to [75Se]-selenite. The intensity of labelling
of all selenoproteins increased up until 48 h, at which time a
steady state of labelling was achieved. Three major [75Se]-
labelled selenoproteins were observed with mean molecular
masses of 58.1, 21.7 and 24.4 kDa. A selenoprotein of
approximately 15 kDa was also moderately expressed. A
number of minor labelled selenoproteins were observed.
No distinct variations in the pattern of intracellular
[75Se]-labelled selenoproteins between four different prep-
arations of HUVEC were observed (Fig. 1, centre panel)
and similarly the selenoprotein profile did not change
over eight passages in HUVEC obtained form a single
cord (Fig. 1, right panel).
Using antiserum to rat TR and human TR, we have
previously identified by Western blotting the 58.1-kDa
[75Se]-labelled band in HUVEC as TR.Western blotting with
antiserum to rat testis PHGPX demonstrated an immunor-
eactive band that co-migrated with the 21.7-kDa [75Se]-
labelled band. The same approach using antiserum to human
cyGPX failed to visualise an immunoreactive band in
HUVEC. However, purified human cyGPX (Sigma Chem-
ical Co., Poole, UK) co-migrated with an identical Rf to the
24.4-kDa protein [75Se]-labelled band on the SDS-PAGE gel.
The 58-, 21.7- and 24.4-kDa 75Se-selenoproteins observed on
the autoradiograph of the SDS-PAGE gels were thus consid-
ered to represent TR, PHGPX and cyGPX, respectively.
3.2. Selenoproteins expressed by human EC and the cell line
EAhy926
The pattern of [75Se]-labelled selenoproteins found in
HCAEC and HUVEC were almost identical (Fig. 2). TR
appeared to be expressed to a higher degree in HCAEC than
in HUVEC and mass measurements (Table 1) confirmed this.
No significant difference was observed in the activities of
cyGPX or PHGPX between HCAEC and HUVEC (Table 1).
The [75Se]-selenoprotein expression in venous EC and
arterial EC isolated from the same umbilical cord differed
only slightly. In HUVEC an additional selenoprotein with a
molecular mass of approximately 27 kDa was labelled,
Table 1
Selenoproteins expressed by EC and the EC line EAhy926
HUVEC HCAEC EAhy926 BAEC
CyGPX activity (mU/mg protein) 86F 0.7 88F 0.03 23F 0.5** 115F 7.0
158F 24.5*
PHGPX activity (mU/mg protein) 7.15F 2.09 8.36F 0.01 4.41F1.86 4.54F 0.76
12.5F 3.0
TR concentration (ng/mg protein) 721F 63 1245F 335* 871F149 ND
1002F 267
TR activity (mU/mg protein) 8.9F 0.60 24.4F 0.34** 11.7F 1.37 1.06F 0.16**
Results for EAhy926 are given for cells grown in basal culture medium and results in italics are from cells grown in basal medium supplemented with 40 nM
sodium selenite.
TR was not detectable (ND) in BAEC because of the lack of cross-reactivity of the antisera with bovine TR.
* Results significantly different from HUVEC, P< 0.05.
** Results significantly different from HUVEC, P< 0.001.
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which was not observed in HUAEC. TR expression in
HUAEC also appeared to be slightly greater than in
HUVEC (Fig. 3).
The pattern of selenoprotein expression in EAhy926 cells
closely resembled that observed in HUVEC (Fig. 4). The
levels of TR and PHGPX in HUVEC were not significantly
different to the levels found in EAhy926 cells grown in the
basal medium or when supplemented with 40 nM selenite
(Table 1). The activity of cyGPX in EAhy926 grown in
basal medium was significantly lower than that found in
HUVEC, however, EAhy926 cells supplemented with 40
nM selenite had significantly higher activities of cyGPX
than HUVEC (Table 1). Supplementation with 40 nM
selenite significantly (P < 0.05) increased the expression
of TR, cyGPX and PHGPX in EAhy926 cells.
3.3. Selenoprotein expression in BAEC and PAEC
Compared to HUVEC, PAEC showed quite distinct
differences in the pattern of [75Se]-labelled selenoproteins
(Fig. 5, left panel). TR was not the most prominently
labelled selenoprotein in PAEC but rather a selenoprotein
of 15 kDa.
The [75Se]-labelling of many selenoproteins in BAEC
was significantly less than in HUVEC (Fig. 5, right panel).
In particular, the expression of the TR band was much less
in BAEC than HUVEC, an observation that was confirmed
by activity measurements of TR (Table 1).
3.4. Se content of culture medium
The EGM2 used for the culture of HUVEC, HCAEC and
HUAEC had a Se content of 30F 2 nM, which was not
significantly different to the Se content of EGM used for the
Fig. 4. Autoradiograph of an SDS-PAGE gel of the intracellular
selenoproteins of HUVEC and EAhy926 cells labelled with [75Se]-selenite
(0.02 MBq/ml) for 48 h. Lane 1, HUVEC; lane 2, EAhy926 cells. Both
lanes were loaded with 25-Ag protein. The selenoprotein bands representing
cyGPX, PHGPX and TR are indicated.
Fig. 3. Autoradiograph of an SDS-PAGE gel of the intracellular
selenoproteins of HUVEC and HUAEC labelled with [75Se]-selenite
(0.02 MBq/ml) for 48 h. Both HUVEC and HUAEC were isolated from a
single umbilical cord and samples were taken from duplicate flasks. Lanes 1
and 2, HUVEC; lanes 3 and 4, HUAEC. Each lane was loaded with 25-Ag
protein. The selenoprotein bands representing cyGPX, PHGPX and TR are
indicated.
S. Miller et al. / Biochimica et Biophysica Acta 1588 (2002) 85–9390
culture of BAEC (43F 10 nM). In both of these culture
media, Se is present as selenious acid. The Se content of the
DMEM/10% FCS/HAT culture medium used for the culture
of EAhy926 cells was 18F 2 nM, with the Se provided by
the FBS in the form of selenoprotein. The basal M199
medium used to culture PAEC had no detectable Se content,
however, since these cells are grown in the presence of 20%
FBS, the final concentration of Se in this culture medium
was 36F 2 nM present as selenoprotein.
4. Discussion
These studies indicate that for HUVEC, an incubation
period of at least 48 h must be employed to achieve
maximal 75Se labelling of selenoproteins (Fig. 1, left panel).
This contrasts with human thyrocytes where [75Se]-labelling
reaches a steady state by 27 h [5]. This difference may be
due to the variability in selenoprotein turnover between
tissues and possibly different rates of [75Se]-selenite uptake
between cell types.
In primary culture, HUVEC have a limited replication
potential, tending to senesce [27] and, in addition, the
activities of some enzymes have been reported to vary with
successive passages [28]. We observed no differences in the
[75Se]-selenoprotein labelling of HUVEC throughout eight
passages of the same preparation under identical growth
conditions (Fig. 1, right panel), arguing that the expression
of selenoproteins in HUVEC remains constant over at least
eight passages. In addition, we found that the selenoprotein
profile in four individual preparations of HUVEC showed
no marked variability between preparations (Fig. 1, centre).
We have also confirmed our previous observation that
HUVEC show dominant expression of the 58.1-kDa sele-
noprotein, TR [6]. Two other major [75Se]-selenoproteins
expressed by HUVEC, which were labelled to a much lesser
extent than TR, had molecular masses of 21.7 and 24.4 kDa
and were provisionally identified as cyGPX and PHGPX,
Fig. 5. Left. Autoradiograph of an SDS-PAGE gel of PAEC labelled with [75Se]-selenite (0.02 MBq/ml) for 48 h. The lane was loaded with 25 Ag of protein.
Right. Autoradiograph of an SDS-PAGE gel of the intracellular selenoproteins of HUVEC and BAEC labelled with [75Se]-selenite (0.02 MBq/ml) for 48 h.
Lane 1, HUVEC; lane 2, BAEC. Both lanes were loaded with 25-Ag protein. The selenoprotein bands representing cyGPX, PHGPX and TR are indicated.
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respectively. Since identification was based on co-migration
with purified material and by Western blotting, we cannot
exclude the possibility that selenoproteins with identical
molecular mass co-migrate with these peroxidases on the
SDS-PAGE system.
EC show functional differences according to the vascular
bed from which they are derived. Arterial EC differ from
venous EC in a number of aspects, such as the production of
angiotensin-converting enzyme, ability to form prostacyclin
[11] and their cell adhesion molecule response to cytokine
stimulation [12]. We compared selenoprotein expression in
a range of primary human EC cells using similar culture
conditions that included keeping the concentration and
chemical form of Se in the culture medium constant. The
[75Se]-selenoprotein profiles of HUVEC and HCAEC were
remarkably similar, with the only observable difference
being a slight increased expression of TR in HCAEC that
was confirmed by assay of TR concentration. The [75Se]-
labelled selenoprotein profiles of EC isolated from the
human umbilical vein (which is arterial-like in the umbilical
cord) and human umbilical artery of the same umbilical cord
were also very similar. The most obvious difference was that
HUVEC expressed an additional selenoprotein (27 kDa)
when compared to HUAEC (Fig. 2). We did not characterise
this selenoprotein but it has a molecular mass similar to type
I iodothyronine deiodinase [29].
Distinct differences in the pattern of selenoprotein
expression between human EC and EC isolated from bovine
and porcine vascular beds were observed. In HUVEC and
other human EC studied, TR was the dominantly [75Se]-
labelled selenoprotein. In PAEC the expression of TR was
relatively weak, the predominant selenoprotein having an
approximate molecular mass of 15 kDa (Fig. 5 left panel).
This 15-kDa [75Se]-selenoprotein was also found in
HUVEC but labelled to a lesser extent. The identity of the
15-kDa selenoprotein was not established, although its
electrophoretic mobility is consistent with it being either
the uncharacterised 15-kDa selenoprotein described by
Gladyshev et al. [30] or the Se-containing protein, epider-
mal fatty acid-binding protein (E-FABP) [30]. Masouye´ et
al. [31] have demonstrated the presence of E-FABP in
HUVEC but they were unable to detect the protein in the
endothelium of the umbilical vein from which the EC were
isolated, suggesting that the expression of E-FABP may be
induced by cell culture.
The pattern of [75Se]-selenoprotein expression in BAEC
also differed considerably from that observed in HUVEC
(Fig. 5, right panel). The [75Se]-labelling of the majority of
selenoproteins was significantly lower in BAEC compared
to HUVEC and TR expression and activity was consider-
ably lower in BAEC than in HUVEC (Table 1). The
expression of selenoproteins is modified by the Se status
of the cell. However, the Se content and the chemical form
of Se (ie selenious acid) present in the culture medium for
HUVEC (EGM2) and BAEC (EGM) were identical. This
suggests that differing selenoprotein profiles seen in
HUVEC and BAEC is not a consequence of altered Se
status.
The selenoprotein profile found for EAhy926 cells was
very similar to HUVEV and HCAEC, however, the activity
of cyGPX in EAhy926 grown in basal medium was sig-
nificantly lower than in HUVEV or HCAEC (Table 1).
Inclusion of 40 nM selenite into the basal culture medium
resulted in significant increases in the expression of each of
the selenoenzymes, such that cyGPX activity increased to
levels that were significantly higher than that found in
HUVEC (Table 1). These data suggest that the small differ-
ences in selenoenzyme activity observed between HUVEC
and EAhy926 grown in basal medium are due to the limiting
supply of Se in the basal medium used to culture EAhy926.
This basal medium has Se included as selenoprotein incor-
porated into the FBS. The Se in extracellular selenoproteins
is not readily available to the cell whilst selenite is rapidly
taken up by the cell and utilised for selenoprotein synthesis.
This study has firmly established the suitability and
consistency of using EC from the human umbilical vein
as a model to study the effects of Se on EC function in
relation to atheroma development in the coronary artery. EC
isolated from pig and bovine aorta showed marked differ-
ences in selenoprotein profile when compared to human
cells, particularly as regards the expression of the antiox-
idant enzyme TR. Only small differences were observed in
selenoprotein expression and activity in EC originating from
the coronary artery and other various human vasculature and
the human cell line EAhy926.
We conclude that whilst the most appropriate cell culture
model for the study of selenoprotein expression in athero-
sclerotic disease in man might be HCAEC, the supply of
such cells is limited and even then the cells are often
isolated from diseased vessels. Our studies suggest that
HUVEC and possibly EAhy926 cells are suitable alternative
model systems to HCAEC in which the role of selenopro-
teins in protecting against atheroma formation can be
studied.
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